Get Started Today!
TFC Group Photo

Austin IVF Receives Major Private Equity Investment; Forms National Network

Austin IVF Receives Major Private Equity Investment; Forms National Network

Patients to Benefit from Larger Pool of Data, Greater Access to Research

TFC in the news Austin, TX – August 19, 2015 – Austin IVF, the largest in vitro fertilization (IVF) laboratory in Central Texas, has received a major private equity investment from funds managed by MTS Health Investors, LLC, a New York based healthcare private equity firm. In addition, they announced the formation of Ovation Fertility, a national network of assisted reproductive technology laboratories headquartered in Los Angeles, California.

Ovation Fertility is committed to advancing industry standards through collaborative partnerships with pioneering physicians and scientists. Austin IVF is one of six U.S. laboratories included in the initial formation of Ovation Fertility. Financial terms of the deal were not disclosed.

Dr. Kaylen Silverberg, co-founder of Ovation Fertility as well as Medical Director and co-founder of both Austin IVF and the Texas Fertility Center, says Ovation Fertility’s acquisition of Austin IVF will boost opportunities for women’s reproductive success in Central Texas and beyond.

“Patients will benefit from the integration of an array of technologies and services that are simply not available to individual fertility laboratories”, said Dr. Silverberg. In addition, while all Ovation Fertility laboratories are known for outstanding pregnancy rates, each founding laboratory brings a different strength to the company, from excellence in clinical research to operational and strategic expertise.

Most IVF laboratories in the U.S. are independent entities and, thus, have limited capabilities and markets, explained Dr. Silverberg. Now as an integral part of Ovation Fertility’s network, each Ovation Fertility program will be able to leverage data and industry best practices to create the world’s leading network of IVF laboratories. Ovation Fertility’s Austin-based laboratory will soon add a new suite of services and significantly improve patient access to novel techniques related to IVF, including research and clinical trials.

“Reproductive health is a science. As is true with all science, there are enormous advantages that come with access to data, research and best practices, namely, improved outcomes for patients. And when the outcome is a son or daughter, what could be more valuable than that?” said Dr. Silverberg.

About Ovation Fertility
Ovation Fertility, founded in 2015 and headquartered in Los Angeles, California, is a premier network of assistive reproductive technology (“ART”) laboratories performing all aspects of treatment and testing for hopeful parents, including embryology, andrology and genetics services as part of the in vitro fertilization process. The company partners with prominent physician clinics that are committed to advancing the industry standard in IVF services. Ovation Fertility’s capital partner is MTS Health Investors, a healthcare private equity firm that makes investments in operating companies within the healthcare industry. For more information, visit www.ovationfertility.com.

About Austin IVF
Austin IVF is an independent in vitro fertilization laboratory located in Austin, Texas and is the largest such program in Central and South Texas. Founded in 2005, Austin IVF has been a regional pioneer in fertility medicine. Among Austin IVF’s milestones, it was the first IVF laboratory in the region to successfully use frozen eggs to help couples conceive and deliver healthy children, to employ micro-surgical lasers to perform embryo hatching and embryo biopsy, and to use time-lapse photographic imaging to assess embryo health and developmental potential, among other accomplishments. For more information, visit www.austinivf.com.

Comments are closed.